158 related articles for article (PubMed ID: 21439992)
1. Recent data on intratumor estrogens in breast cancer.
Lønning PE; Haynes BP; Straume AH; Dunbier A; Helle H; Knappskog S; Dowsett M
Steroids; 2011 Jul; 76(8):786-91. PubMed ID: 21439992
[TBL] [Abstract][Full Text] [Related]
2. Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status.
Lønning PE; Helle H; Duong NK; Ekse D; Aas T; Geisler J
J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):31-41. PubMed ID: 19591931
[TBL] [Abstract][Full Text] [Related]
3. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status.
Geisler J; Suzuki T; Helle H; Miki Y; Nagasaki S; Duong NK; Ekse D; Aas T; Evans DB; Lønning PE; Sasano H
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):237-41. PubMed ID: 19883757
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.
Geisler J
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):245-53. PubMed ID: 14623518
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
[TBL] [Abstract][Full Text] [Related]
7. Estrogen metabolism and risk of breast cancer in postmenopausal women.
Fuhrman BJ; Schairer C; Gail MH; Boyd-Morin J; Xu X; Sue LY; Buys SS; Isaacs C; Keefer LK; Veenstra TD; Berg CD; Hoover RN; Ziegler RG
J Natl Cancer Inst; 2012 Feb; 104(4):326-39. PubMed ID: 22232133
[TBL] [Abstract][Full Text] [Related]
8. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.
Pasqualini JR; Chetrite G; Blacker C; Feinstein MC; Delalonde L; Talbi M; Maloche C
J Clin Endocrinol Metab; 1996 Apr; 81(4):1460-4. PubMed ID: 8636351
[TBL] [Abstract][Full Text] [Related]
9. Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma.
Pasqualini JR; Cortes-Prieto J; Chetrite G; Talbi M; Ruiz A
Int J Cancer; 1997 Mar; 70(6):639-43. PubMed ID: 9096642
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral estrogen disposition in breast cancer.
Haynes BP; Straume AH; Geisler J; A'Hern R; Helle H; Smith IE; Lønning PE; Dowsett M
Clin Cancer Res; 2010 Mar; 16(6):1790-801. PubMed ID: 20215536
[TBL] [Abstract][Full Text] [Related]
11. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
12. Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.
Saez S; Martin PM; Chouvet CD
Cancer Res; 1978 Oct; 38(10):3468-73. PubMed ID: 688231
[TBL] [Abstract][Full Text] [Related]
13. Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer.
Folkerd EJ; Dixon JM; Renshaw L; A'Hern RP; Dowsett M
J Clin Oncol; 2012 Aug; 30(24):2977-80. PubMed ID: 22802308
[TBL] [Abstract][Full Text] [Related]
14. Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism.
Brueggemeier RW; Gu X; Mobley JA; Joomprabutra S; Bhat AS; Whetstone JL
Ann N Y Acad Sci; 2001 Dec; 948():51-66. PubMed ID: 11795395
[TBL] [Abstract][Full Text] [Related]
15. The potential role of estrogen in aromatase regulation in the breast.
Yue W; Berstein LM; Wang JP; Clark GM; Hamilton CJ; Demers LM; Santen RJ
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):157-64. PubMed ID: 11850220
[TBL] [Abstract][Full Text] [Related]
16. Exploring breast cancer estrogen disposition: the basis for endocrine manipulation.
Lønning PE; Haynes BP; Straume AH; Dunbier A; Helle H; Knappskog S; Dowsett M
Clin Cancer Res; 2011 Aug; 17(15):4948-58. PubMed ID: 21791635
[TBL] [Abstract][Full Text] [Related]
17. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
18. On the significance of in situ production of oestrogens in human breast cancer tissue.
Blankenstein MA; Maitimu-Smeele I; Donker GH; Daroszewski J; Milewicz A; Thijssen JH
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):891-6. PubMed ID: 1314086
[TBL] [Abstract][Full Text] [Related]
19. Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer.
Flågeng MH; Knappskog S; Gjerde J; Lønning PE; Mellgren G
PLoS One; 2015; 10(8):e0134351. PubMed ID: 26247365
[TBL] [Abstract][Full Text] [Related]
20. Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors.
Lønning PE; Haynes BP; Dowsett M
Eur J Cancer; 2014 Apr; 50(6):1055-64. PubMed ID: 24507547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
